XML 29 R5.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 300,790 $ 334,294 $ 397,991
Cost of sales 104,426 151,998 242,878
Gross profit 196,364 182,296 155,113
Operating expenses:      
Selling and marketing 93,590 118,311 144,496
Research and development 5,628 6,296 10,102
General and administrative 117,949 125,463 131,432
Total operating expenses 217,167 250,070 286,030
Loss from operations (20,803) (67,774) (130,917)
Interest expense 19,326 10,412 13,649
Interest income (8,954) (16,644) (23,173)
Other income, net (18,931) (33,563) (5,200)
Change in fair value of warrant liabilities (487) (3,067) (11,919)
Foreign currency transaction (gain) loss, net (5,819) 4,638 (2,385)
Loss before provision for income taxes (5,938) (29,550) (101,889)
Income tax expense (benefit) 3,581 (452) (1,773)
Net loss (9,519) (29,098) (100,116)
Comprehensive loss, net of tax:      
Foreign currency translation adjustments 5,519 (3,917) 1,494
Comprehensive loss $ (4,000) $ (33,015) $ (98,622)
Net loss per share      
Basic (in dollars per share) $ (0.08) $ (0.23) $ (0.76)
Diluted (in dollars per share) $ (0.16) $ (0.36) $ (0.76)
Weighted average common stock outstanding      
Basic (in shares) 126,378,509 123,827,372 131,680,605
Diluted (in shares) 135,798,202 142,492,575 131,680,605